Antimicrobial Susceptibility Testing Market to Reach USD 8.12 Billion by 2030, Growing at a 5.6% CAGR

𝐀𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐒𝐮𝐬𝐜𝐞𝐩𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

The global antimicrobial susceptibility testing (AST) market is witnessing significant growth, driven by rising incidences of infectious diseases, increasing antibiotic resistance, and advancements in diagnostic technologies. The market was valued at USD 5.54 billion in 2023 and is projected to grow at a CAGR of 5.6% from 2024 to 2030, reaching USD 8.12 billion by the end of the forecast period. This press release delves into the key growth drivers, country-specific trends, and significant developments shaping the market.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/1281/
𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐕𝐢𝐞𝐭𝐧𝐚𝐦

Vietnam has emerged as a significant player in the antimicrobial susceptibility testing market due to its growing healthcare infrastructure and government initiatives. The Vietnamese market is witnessing increased adoption of AST devices in hospitals and diagnostic labs. 𝐑𝐨𝐜𝐡𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 recently expanded its presence in Vietnam, enhancing the availability of advanced AST solutions.

𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝

Thailand's AST market is driven by its commitment to combat antibiotic resistance. The government's collaboration with 𝐛𝐢𝐨𝐌é𝐫𝐢𝐞𝐮𝐱 𝐒𝐀 has resulted in extensive training programs for healthcare professionals. Additionally, the rise of telemedicine has propelled the demand for AST kits in rural areas, providing significant market opportunities.

𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐉𝐚𝐩𝐚𝐧

The Japanese antimicrobial susceptibility testing market is characterized by mergers and acquisitions among leading players. 𝐓𝐡𝐞𝐫𝐦𝐨 𝐅𝐢𝐬𝐡𝐞𝐫 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 recently acquired a local diagnostic company, enhancing its distribution network. Furthermore, Japan's focus on precision medicine has led to increased investment in AST technologies.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/1281/
𝐔𝐩𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐂𝐡𝐢𝐧𝐚

China's market is rapidly evolving with advancements in AST technologies. 𝐔𝐩𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐂𝐡𝐢𝐧𝐚 launched a new range of automated AST devices in China, addressing the growing demand for efficient diagnostic tools. The Chinese government's policies supporting healthcare innovation further boost the market.

𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚

South Korea is capitalizing on its robust healthcare system to drive AST adoption. Key developments include 𝐀𝐛𝐛𝐨𝐭𝐭 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬 partnering with Korean biotech firms to develop cutting-edge AST systems. The rise in hospital-acquired infections has also increased demand for reliable susceptibility testing solutions.

𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞

Singapore is setting a benchmark in antimicrobial resistance research. Collaborations between local institutions and global companies like 𝐒𝐢𝐞𝐦𝐞𝐧𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐢𝐧𝐞𝐞𝐫𝐬 are leading to breakthroughs in AST technologies. Singapore's strategic focus on medical tourism also amplifies market growth.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/1281/

𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬

The United States remains a dominant market for antimicrobial susceptibility testing. Recent mergers, such as 𝐁𝐞𝐜𝐭𝐨𝐧, 𝐃𝐢𝐜𝐤𝐢𝐧𝐬𝐨𝐧 𝐚𝐧𝐝 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 (𝐁𝐃) acquiring a diagnostic startup, underline the industry's consolidation trends. Additionally, rising investments in R&D for rapid AST kits continue to fuel market growth.

𝐔𝐩𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞

Europe's AST market is driven by stringent regulations and a proactive approach to combating antibiotic resistance. 𝐛𝐢𝐨𝐌é𝐫𝐢𝐞𝐮𝐱 𝐒𝐀 expanded its manufacturing capabilities in France, enhancing its production capacity for AST solutions. Moreover, collaborative efforts across the EU aim to standardize testing protocols.

𝐊𝐞𝐲 𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

𝐛𝐢𝐨𝐌é𝐫𝐢𝐞𝐮𝐱 𝐒𝐀 launched an AI-powered AST device in 2024, revolutionizing susceptibility testing.

𝐓𝐡𝐞𝐫𝐦𝐨 𝐅𝐢𝐬𝐡𝐞𝐫 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 opened a new R&D facility in Germany focused on AST advancements.

𝐀𝐛𝐛𝐨𝐭𝐭 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬 announced the development of a portable AST system, targeting rural healthcare markets globally.

Partnerships between 𝐃𝐚𝐧𝐚𝐡𝐞𝐫 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧 and Asian biotech firms are accelerating the commercialization of novel AST technologies.

𝐅𝐨𝐫 𝐚 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐨𝐯𝐞𝐫𝐯𝐢𝐞𝐰, 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐝:https://www.maximizemarketresearch.com/market-report/global-antimicrobial-susceptibility-testing-market/1281/

𝐀𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐒𝐮𝐬𝐜𝐞𝐩𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Manual Antimicrobial Susceptibility Testing Products
Susceptibility Testing Disks
MIC Strips
Susceptibility Testing Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables

𝐛𝐲 𝐓𝐲𝐩𝐞

Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing Types

𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Clinical Diagnostics
Drug Discovery and Development
Epidemiology
Other Applications

𝐛𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫

Hospitals and Diagnostic Centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations (CROs)

𝐛𝐲 𝐌𝐞𝐭𝐡𝐨𝐝

Etest Method
Disk Diffusion
Automated Susceptibility Testing Instruments
Agar Dilution
Genotyping Methods

𝐀𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐒𝐮𝐬𝐜𝐞𝐩𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

1. bioMérieux SA
2. Becton
3. Dickinson and Company
4. Thermo Fisher Scientific
5. Danaher Corporation
6. Bio-Rad Laboratories, Inc.
7. Bruker
8. Roche Diagnostics Limited
9. Accelerate Diagnostics, Inc.
10. Merck KGaA
11. Hi-Media Laboratories
12. Liofilchem S.r.l.
13. Alifax S.r.l.
14. Creative Diagnostics
15. Synbiosis
16. Bioanalyse
17. ZHUHAI DL BIOTECH Co., Ltd.
18. ELITechGroup
19. Mast Group Ltd.
20. CONDALAB
21. Genefluidics, Inc.
22. Biotron Ltd
23. InvivoGen
24. MP Biomedicals
25. QuantaMatrix Inc.
26. PML Microbiologicals Inc.
27. Other key players

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐖𝐡𝐚𝐭'𝐬 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠:

♦ Scanning Electron Microscopes Market https://www.maximizemarketresearch.com/market-report/scanning-electron-microscopes-market/187558/

♦ Single Cell Omics Market https://www.maximizemarketresearch.com/market-report/single-cell-omics-market/187051/

♦ Single Use Filtration Assembly Market https://www.maximizemarketresearch.com/market-report/single-use-filtration-assembly-market/187509/

♦ Sleep Apnea Implants Market https://www.maximizemarketresearch.com/market-report/sleep-apnea-implants-market/188223/

♦ Sports Medicine Market https://www.maximizemarketresearch.com/market-report/sports-medicine-market/613/

♦ Stem Cell Banking Market https://www.maximizemarketresearch.com/market-report/stem-cell-banking-market/13540/

♦ Sterilization Services Market https://www.maximizemarketresearch.com/market-report/sterilization-services-market/163286/

♦ Subperiosteal Implants Market https://www.maximizemarketresearch.com/market-report/subperiosteal-implants-market/82674/

♦ T Cell Therapy Market https://www.maximizemarketresearch.com/market-report/t-cell-therapy-market/124121/

♦ Traumatic Brain Injuries Treatment Market https://www.maximizemarketresearch.com/market-report/traumatic-brain-injuries-treatment-market/14716/

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

𝐀𝐛𝐨𝐮𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.